Day: December 13, 2019

TORONTO, Dec. 13, 2019 (GLOBE NEWSWIRE) — North American Financial 15 Split Corp. (the “Company”) announces a Class A share consolidation. In connection with the extension of the termination date of the Company, a special retraction right was offered allowing existing shareholders to tender one or both classes of shares and receive a retraction price based on the November 29, 2019 net asset value per unit.  In aggregate, more Preferred shares were tendered for retraction than Class A shares.  The purpose of the share consolidation is to maintain the requirement that an equal number of Class A shares and Preferred shares remain outstanding. Immediately after the special retraction payment on or before December 16, 2019, there will be 16,552,263 Preferred shares and 18,761,656 Class A shares outstanding.  In order to restore an equal...

CHICAGO, Dec. 13, 2019 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application specific products and solutions, announced today the election of David Blom and Angelo Pantaleo as directors of the Company.Chairman Walter J. Aspatore said, “We are pleased to welcome David and Angelo to our board of directors and look forward to leveraging their extensive experience as CEOs and directors. David is an experienced healthcare administration executive who understands the complexity and trends of the healthcare delivery environment and will bring additional valuable insight to assist Methode in driving value creation with our Dabir Surface (medical device) offering. Angelo brings a wealth of expertise and will be a tremendous asset in supporting Methode’s focus on growing its industrial...

RADNOR, Pa., Dec. 13, 2019 (GLOBE NEWSWIRE) — Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that the Board of Directors of Marinus granted non-qualified stock options to purchase an aggregate of 121,000 shares of its common stock to new employees, with a grant date of December 11, 2019.The options have an exercise price of $1.78 per share, which is equal to the closing price of Marinus’s common stock on December 11, 2019, the date of grant. The options will vest and become exercisable as to 25 percent of the shares on the one-year anniversary of the recipient’s start date, and will vest and become exercisable as to the remaining 75 percent of the shares...

CANTON, Ohio, Dec. 13, 2019 (GLOBE NEWSWIRE) — Concrete Leveling Systems, Inc. (OTC PINK: CLEV) (the Company) and Jericho Associates, Inc. (Jericho), its gaming and hospitality division, are pleased to advise its Shareholders of the following.Concrete Leveling Systems, Inc. (CLEV – OTC) is pleased to disclose that its casino gaming and hospitality division, Jericho Associates, Inc. (Jericho) with its partners and associates (the “Partnership”) has entered into a formal binding Term Sheet with a California Tribe to design, build, and operate a new casino gaming and hotel resort on a major highway location. The comprehensive Term Sheet designates the Partnership to be its Development Partner and gives it the right to a seven (7) year management contract, earning a share of the net profits, or to be its slot machine vendor whereby...

AUDUBON, Pa., Dec. 13, 2019 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced the appointment of Robert Douglas to the Company’s Board of Directors, and the departure of Board member Kurt Wheeler, effective December 11, 2019.   Mr. Wheeler has assumed a role that precludes him from serving on public company Boards. Mr. Douglas has nearly thirty years of experience in medical device technology, with particular expertise in digital health.  Currently Mr. Douglas serves as the President and Chief Operating Officer in the Office of the CEO for ResMed, Inc. (NYSE:RMD, ASX:RMD), a medical device and software applications company specializing in cloud-connected devices that diagnose, treat and manage respiratory disorders and improve care in out-of-hospital settings.  Mr....

MCLEAN, Va., Dec. 13, 2019 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) announces the pricing of the SB69 offering, a multifamily mortgage-backed securitization backed by small balance loans underwritten by Freddie Mac and issued by a third-party trust. The company expects to guarantee approximately $413 million in Multifamily SB Certificates (SB69 Certificates), which are anticipated to settle on or about December 20, 2019. Freddie Mac Small Balance Loans generally range from $1 million to $6 million and are generally backed by properties with five or more units. This is the twelfth SB Certificate transaction in 2019.SB69 PricingDetails:Co-Lead Managers and Joint Bookrunners: J.P. Morgan Securities LLC and Wells Fargo Securities, LLCCo-Managers: FHN Financial Capital Markets, Mischler Financial Group, Inc., Stifel, Nicolaus &...

DALLAS, Dec. 13, 2019 (GLOBE NEWSWIRE) — North Dallas Bank & Trust Co. (NODB) announces the election of two new members to the Board of Directors. Mary Pat Higgins, President/CEO of the Dallas Holocaust and Human Rights Museum and Timothy John Jordan, Managing Director of Dallas-Capital Markets for JLL were elected for service effective January 01, 2020. North Dallas Bank & Trust Co. is an independent bank established in 1961 with five locations and assets of $1.3 Billion. For further information about this announcement, contact W. Michael Shipman, Chairman/CEO or Larry Miller, President of North Dallas Bank & Trust Co.Contact:972.716.7100